Date	Period	Revenue/Estimate	Earnings Call
Apr 24, 2025	2025/Q1	-- / 254.000B	--
Jan 30, 2025	2024/Q4	-- / 289.152B	--
Oct 25, 2024	2024/Q3	315.700B / 280.871B	--
Jul 25, 2024	2024/Q2	315.911B / 276.349B	--
Apr 24, 2024	2024/Q1	236.900B / 242.461B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 24, 20252025/Q1-- / 254.000B--

Jan 30, 20252024/Q4-- / 289.152B--

Oct 25, 20242024/Q3315.700B / 280.871B--

Jul 25, 20242024/Q2315.911B / 276.349B--

Apr 24, 20242024/Q1236.900B / 242.461B--

Unlock Free Earnings Estimates

Open Account

Chugai Pharmaceutical: Consolidated financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] supplementary materials

Oct 25 04:00 ET

Chugai Pharmaceutical: Notice regarding revisions to the dividend forecast for the fiscal year ending 2024/12

Oct 25 04:00 ET

Chugai Pharmaceutical: Notice regarding revisions to earnings forecasts

Oct 25 04:00 ET

Chugai Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

Oct 25 04:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Dec 5, 2024

Buy

No Data